Author

H. Sullivan

The University of Melbourne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:rat· 1 Approach:statistical model· 1

Frequent Co-Authors

C. Luo· 2 shared K. Worthington· 2 shared N. C. Gianneschi· 2 shared Y. Liang· 2 shared A. Ferrier· 1 shared A. Glasgow· 1 shared A. Mellon· 1 shared Adam C. Martyn· 1 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

C. Luo

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance

Ksenija Nesic, John J. Krais, Yifan Wang, Cassandra J. Vandenberg, Pooja Patel, Kathy Qi Cai, Tanya Todorova Kwan, Elizabeth Lieschke, Gwo‐Yaw Ho, Holly E. Barker, Justin Bedő, Silvia Casadei, Andrew Farrell, Marc R. Radke, Kristy Shield‐Artin, , Lyndal S. Edwards

This study identifies secondary splice-site mutations in BRCA1 that drive exon skipping and PARP inhibitor resistance in ovarian and breast cancer.

Molecular Cancer · Aug 5, 2024Peer-reviewedGenetic & Genomic Medicine

Inflammation-Responsive Micellar Nanoparticles from Degradable Polyphosphoramidates for Targeted Delivery to Myocardial Infarction

Y. Liang, H. Sullivan, K. Carrow, J. Korpanty, K. Worthington, C. Luo, K. L. Christman, N. C. Gianneschi

This paper develops biodegradable micellar nanoparticles responsive to inflammation, showing targeted accumulation in myocardial infarction sites in rats.

bioRxiv · Nov 11, 2022Biochemistry

Enzyme-Responsive Nanoparticles for the Targeted Delivery of an MMP Inhibitor to the Heart post Myocardial Infarction

H. Sullivan, Y. Liang, K. Worthington, C. Luo, N. C. Gianneschi, K. Christman

This paper develops enzyme-responsive nanoparticles that deliver an MMP inhibitor to the heart after myocardial infarction, showing targeted retention and controlled drug release.

bioRxiv · Mar 7, 2022 · PreprintBioengineering